A Comprehensive Assessment of (68)Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients

We prospectively investigated the performance of the prostate-specific membrane antigen (PSMA) ligand (68)Ga-PSMA-11 for detecting prostate adenocarcinoma in patients with elevated levels of prostate-specific antigen (PSA) after initial therapy. Methods: (68)Ga-PSMA-11 hybrid PET was performed on 2,...

Descripción completa

Detalles Bibliográficos
Autores principales: Abghari-Gerst, Monica, Armstrong, Wesley R., Nguyen, Kathleen, Calais, Jeremie, Czernin, Johannes, Lin, David, Jariwala, Namasvi, Rodnick, Melissa, Hope, Thomas A., Hearn, Jason, Montgomery, Jeffrey S., Alva, Ajjai, Reichert, Zachery R., Spratt, Daniel E., Johnson, Timothy D., Scott, Peter J.H., Piert, Morand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2022
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973291/
https://www.ncbi.nlm.nih.gov/pubmed/34326126
http://dx.doi.org/10.2967/jnumed.121.262412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973291/
https://www.ncbi.nlm.nih.gov/pubmed/34326126
http://dx.doi.org/10.2967/jnumed.121.262412

Ejemplares similares